Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling

Cell Biochemistry and Biophysics

Volumn 71, Issue 3, 2015, Pages 1349-1356

  Jin, Di ^a   Cao, Ming ^a   Mu, Xin ^a   Yang, Guoliang ^a   Xue, Wei ^a   Huang, Yiran ^a   Chen, Haige ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Akt mediated; Catalpol; Rehmannia glutinosa; T24 bladder cancer cells

Indexed keywords

REHMANNIA GLUTINOSA;

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE INHIBITOR; CATALPOL; IRIDOID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B;

APOPTOSIS; BLADDER TUMOR; CELL CYCLE G2 PHASE; CELL DIVISION; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE INHIBITORS; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IRIDOID GLUCOSIDES; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 84930086082     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-0355-0     Document Type: Article

References (37)

1. Dong, Z., & Chen, C. X. (2013). Effect of catalpol on diabetic nephropathy in rats. Phytomedicine,20, 1023–1029.
2. Feng, Y., Liu, Z., Peng, Y., et al. (2013). Validated LC-MS method for simultaneous quantitation of catalpol and harpagide in rat plasma: Application to a comparative pharmacokinetic study in normal and diabetic rats after oral administration of Zeng-Ye-Decoction. Biomedical Chromatography,27, 1503–1510.
3. Chen, C., Chen, Z., Xu, F., et al. (2013). Radio-protective effect of catalpol in cultured cells and mice. Journal of Radiation Research,54, 76–82.
4. Chen, W., Li, X., Jia, L. Q., et al. (2013). Neuroprotective activities of catalpol against CaMKII-dependent apoptosis induced by LPS in PC12 cells. British Journal of Pharmacology,169, 1140–1152.
5. Choi, H. J., Jang, H. J., Chung, T. W., et al. (2013). Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells. Fitoterapia,86, 19–28.
6. Bi, J., Jiang, B., Zorn, A., et al. (2013). Catalpol inhibits LPS plus IFN-gamma-induced inflammatory response in astrocytes primary cultures. Toxicology in Vitro,27, 543–550.
7. Wan, D., Xue, L., Zhu, H., et al. (2013). Catalpol induces neuroprotection and prevents memory dysfunction through the cholinergic system and BDNF. Evidence-Based Complementary and Alternative Medicine,2013, 134852.
8. Zhang, X., Jin, C., Li, Y., et al. (2013). Catalpol improves cholinergic function and reduces inflammatory cytokines in the senescent mice induced by d-galactose. Food and Chemical Toxicology,58, 50–55.
9. Huang, C., Cui, Y., Ji, L., et al. (2013). Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult. Pharmaceutical Biology,51, 463–473.
10. Saracoglu, I., & Harput, U. S. (2012). In vitro cytotoxic activity and structure activity relationships of iridoid glucosides derived from Veronica species. Phytotherapy Research,26, 148–152.
11. Saracoglu, I., Oztunca, F. H., Nagatsu, A., et al. (2011). Iridoid content and biological activities of Veronica cuneifolia subsp. cuneifolia and V. cymbalaria. Pharmaceutical Biology,49, 1150–1157.
12. Pungitore, C. R., Leon, L. G., Garcia, C., et al. (2007). Novel antiproliferative analogs of the Taq DNA polymerase inhibitor catalpol. Bioorganic & Medicinal Chemistry Letters,17, 1332–1335.
13. Nguyen, A. T., Fontaine, J., Malonne, H., et al. (2005). A sugar ester and an iridoid glycoside from Scrophularia ningpoensis. Phytochemistry,66, 1186–1191.
14. Pungitore, C. R., Ayub, M. J., Borkowski, E. J., et al. (2004). Inhibition of Taq DNA polymerase by catalpol. Cellular and Molecular Biology (Noisy-Le-Grand),50, 767–772.
15. Zhu, Y., Mao, Y., Chen, H., et al. (2013). Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells. Cancer Cell International,13, 54.
16. Shen, Z., Shen, T., Wientjes, M. G., O’Donnell, M. A., & Au, J. L. (2008). Intravesical treatments of bladder cancer. Pharmaceutical Research,25(7), 1500–1510.
17. Bai, L., Chen, J., McEachern, D., Liu, L., Zhou, H., et al. (2014). BM-1197: A novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo. PLoS One,9(6), e99404.
18. Zhou, B., Li, Y., Deng, Q., et al. (2013). SRPK1 contributes to malignancy of hepatocellular carcinoma through a possible mechanism involving PI3K/Akt. Molecular and Cellular Biochemistry,379, 191–199.
19. Jiang, S., Zhu, W., Li, C., et al. (2013). alpha-Lipoic acid attenuates LPS-induced cardiac dysfunction through a PI3K/Akt-dependent mechanism. International Immunopharmacology,16, 100–107.
20. Chen, X., Wang, H., Ou-Yang, X. N., et al. (2013). Research on drug resistance mechanism of trastuzumab caused by activation of the PI3K/Akt signaling pathway. Contemporary Oncology (Poznan),17, 363–369.
21. Ma, Y., Lu, C., Li, C., et al. (2013). Overexpression of HSPA12B protects against cerebral ischemia/reperfusion injury via a PI3K/Akt-dependent mechanism. Biochimica et Biophysica Acta,1832, 57–66.
22. FrankeTF, Hornik C. P., Segev, L., Shostak, G. A., & Sugimoto, C. (2003). PI3K/Akt and apoptosis: Size matters. Oncogene,22, 8983–8998.
23. Lee, K. M., Kang, H. A., Park, M., et al. (2012). Interleukin-24 suppresses the growth of vascular smooth muscle cells by inhibiting H(2)O(2)-induced reactive oxygen species production. Pharmacology,90, 332–341.
24. Miyake, N., Chikumi, H., Takata, M., et al. (2012). Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells. Oncology Reports,28, 848–854.
25. Noori, S., & Hassan, Z. M. (2012). Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosis. Free Radical Biology and Medicine,52, 1987–1999.
26. Ma, Y., Hao, X., Zhang, S., et al. (2012). The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Research and Treatment,133, 473–485.
27. Lu, J., Wang, Y., Zhao, W., et al. (2014). Effects of catalpol, l-shikonin and paeonol extracted from radix rehmanniae, radix arnebiaeand cortex moutan on KGF-induced HaCaT cell proliferation. Zhonghua Yi Xue Za Zhi,94, 1265–1269.
28. Garcia, C., Leon, L. G., Pungitore, C. R., et al. (2010). Enhancement of antiproliferative activity by molecular simplification of catalpol. Bioorganic and Medicinal Chemistry,18, 2515–2523.
29. Alnemri, E. S. (1997). Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases. Journal of Cellular Biochemistry,64(1), 33–42.
30. Majeed, R., Hamid, A., Sangwan, P. L., Chinthakindi, P. K., Koul, S., Rayees, S., et al. (2014). Inhibition of phophotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancels of different origin. Cell Death and Disease,5, e1459.
31. Hsu, Y. Y., Liu, C. M., Tsai, H. H., et al. (2010). KMUP-1 attenuates serum deprivation-induced neurotoxicity in SH-SY5Y cells: Roles of PKG, PI3K/Akt and Bcl-2/Bax pathways. Toxicology,268, 46–54.
32. Moon, D. O., Kim, M. O., Choi, Y. H., et al. (2008). Beta-Sitosterol induces G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways. Cancer Letters,264, 181–191.
33. Jin, Y. P., Fishbein, M. C., Said, J. W., et al. (2004). Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Human Immunology,65, 291–302.
34. Isabelle, M., Moreel, X., Gagné, J. P., Rouleau, M., Ethier, C., Gagné, P., et al. (2010). Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry. Proteome Science,8, 22.
35. Pawlowski, J., & Kraft, A. S. (2000). Bax-induced apoptotic cell deat. Proceedings of National Academy of Sciences,97(2), 529–531.
36. Hu, W., Shen, T., & Wang, M. H. (2011). Cell cycle arrest and apoptosis induced by methyl 3,5-dicaffeoyl quinate in human colon cancer cells: Involvement of the PI3K/Akt and MAP kinase pathways. Chemico-Biological Interactions,194, 48–57.
37. Roy, S. K., Srivastava, R. K., & Shankar, S. (2010). Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. Journal of Molecular Signaling,5, 10.